Fate Therapeutics FATE
NASDAQ FATE
$1.61 -0.16 (-9.32%)
At close: Nov 11, 2026 · 4:00 PM EST

Fate Therapeutics (FATE) Interest Expenses (2013 - 2019)

Updated

Analysis

Fate Therapeutics (FATE) Interest Expenses (2013 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 217.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -477.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 269.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Fate Therapeutics 215.18 Mn 76.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 586,000.00
Sep 30, 2019 400,000.00
Jun 30, 2019 409,000.00
Mar 31, 2019 405,000.00
Dec 31, 2018 434,000.00
Sep 30, 2018 429,000.00
Jun 30, 2018 425,000.00
Mar 31, 2018 412,000.00
Dec 31, 2017 412,000.00
Sep 30, 2017 378,000.00
Jun 30, 2017 212,000.00
Mar 31, 2017 266,000.00
Dec 31, 2016 329,000.00
Sep 30, 2016 385,000.00
Jun 30, 2016 435,000.00
Mar 31, 2016 500,000.00
Dec 31, 2015 520,000.00
Sep 30, 2015 600,000.00
Jun 30, 2015 600,000.00
Mar 31, 2015 600,000.00
API Access

Fate Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=FATE&period=max&api_key=YOUR_API_KEY